Mechanism regulating ErbB signaling network in head and neck cancer

头颈癌ErbB信号网络的调控机制

• 批准号: 8774225
• 负责人: RANDALL H KRAMER
• 金额: $ 39.55万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-12-05 至 2015-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8774225
• 关键词: 3-Dimensional; Address; Adhesions; Aggressive behavior; Apoptotic; Cancer Patient; Cell Line; Cell Survival; Cells; Cessation of life; Clinical; Clinical Research; Clinical effectiveness; Communities; Complex; Development; Diagnostic; Disease; Distant Metastasis; Epidermal Growth Factor Receptor; ErbB Receptor Family Protein; Evolution; Family; Family member; Fostering; Future; Goals; Growth; Growth Factor Receptors; Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Head and neck structure; Health; Hour; Human; Hypoxia; Intercellular Junctions; Island; Lead; Ligands; Link; Malignant - descriptor; Malignant Neoplasms; Mediating; Molecular; Molecular Profiling; Molecular Target; NRG1 gene; Neoplasm Metastasis; Operative Surgical Procedures; Oral; Pathological Staging; Patients; Pharmaceutical Preparations; Phosphotransferases; Population; Primary Neoplasm; Process; Radiation therapy; Receptor Signaling; Recurrence; Regulation; Reporting; Resistance; Resistance development; Signal Pathway; Signal Transduction; Solid Neoplasm; Squamous cell carcinoma; Survival Rate; Testing; Therapeutic; Tumorigenicity; Tyrosine Kinase Inhibitor; Variant; Work; Xenograft procedure; autocrine; cancer cell; cancer diagnosis; cell growth; chemotherapeutic agent; chemotherapy; density; dimer; disorder control; inhibitor/antagonist; interest; lymph nodes; malignant mouth neoplasm; mouth squamous cell carcinoma; neoplastic cell; novel; novel therapeutics; outcome forecast; overexpression; prognostic; promoter; receptor; receptor expression; targeted treatment; treatment strategy; tumor; tumor microenvironment; tumor progression

DESCRIPTION (provided by applicant): Invasive squamous cell carcinoma is the most common malignant tumor of the upper aerodigestive tract. Despite advances in surgical and radiotherapeutic approaches for therapy, the overall prognosis of oral and head and neck cancer remains poor primarily due to its aggressive invasive capacity, recurrence, and local and distant metastases. Oral squamous cell carcinomas with regional metastasis have a survival rate close to 50%. There is an urgent need to develop novel molecular targets that yield new effective therapeutic approaches. Squamous cell carcinomas present as tightly associated nests of three-dimensional tumor with extensive cell-cell junctional adhesions that permit cell growth and resistance to apoptotic insults. Our findings implicated the involvement of intercellular adhesions in conferring this protection and revealed that cell-cell contacts provide discrete cell survival signaling. The overall goal of this project is to define the mechanisms that regulate growth factor receptor signaling profiles that lead to more aggressive oral SCC cell populations and to identify how complex cellular microenvironmental interrelationships contribute to development of resistance to inhibitors targeting ErbB axis family members. Recent clinical studies have examined the prognostic relevance of overexpressed ErbB3 in HNSCC and report that elevated ErbB3 correlates with metastatic disease and poor overall patient survival. This project focuses specifically on the overriding hypothesis that in oral SCC development, high-density three-dimensional nests of tumor cells promote shifts in specific ErbB family signaling profiles favoring enhanced proliferation and tumor progression. Aim 1 will investigate how the 3D-tumor microenvironment regulates cell growth. Aim 2 will identify the mechanism controlling ErbB receptor profile in tumor foci. Aim 3 will define the importance of HIF-1α induction of ErbB receptor expression in tumor progression. These proposed studies should foster an increased understanding of the evolution of aggressive HNSCC that could be exploited for the future development of novel therapeutic strategies.

描述(申请人提供)：浸润性鳞状细胞癌是上呼吸道最常见的恶性肿瘤。尽管手术和放射治疗方法在治疗方面取得了进展，但口腔和头颈部癌症的总体预后仍然很差，这主要是由于其侵袭性强、复发以及局部和远处转移。有区域转移的口腔鳞状细胞癌的存活率接近50%。迫切需要开发新的分子靶点，以产生新的有效治疗方法。鳞状细胞癌表现为紧密相关的三维肿瘤巢，具有广泛的细胞-细胞连接粘连，允许细胞生长和抵抗凋亡损伤。我们的发现表明，细胞间的粘连参与了这种保护，并揭示了细胞间的接触提供了离散的细胞生存信号。该项目的总体目标是确定调节生长因子受体信号转导谱的机制，从而导致更具侵袭性的口腔鳞状细胞癌细胞群，并确定复杂的细胞微环境相互关系如何有助于针对ErbB轴家族成员的抑制剂的耐药性的形成。最近的临床研究检测了HNSCC中ErbB3的过度表达与预后的相关性，并报道了ErbB3的升高与转移性疾病和较差的总体患者生存相关。该项目特别关注压倒一切的假设，即在口腔鳞状细胞癌的发展过程中，高密度的三维肿瘤细胞巢促进特定的ErbB家族信号谱的转变，有利于促进增殖和肿瘤进展。目标1将研究3D肿瘤微环境如何调节细胞生长。目的2研究ErbB受体在肿瘤灶中的作用机制。目的3明确缺氧诱导因子-1α诱导ErbB受体表达在肿瘤进展中的重要性。这些拟议的研究将促进对侵袭性HNSCC演变的更多了解，可用于未来新治疗策略的开发。